Empowering You to Diagnose Endometriosis at First Patient Visit

DIAGNOSTIC SUPPORT

  • 99% accuracy, 95% sensitivity, 96% specificity
  • Testing takes less than an hour and provides instant results
  • Detects all disease stages
  • Auto-diagnostic & self calibrating

PATIENT CENTRED EXPERIENCE

  • For all ages, premenarche to post menopause
  • Painless & trauma informed
  • Minimal patient preparation
  • Patients remain fully clothed during test

CLINICAL FIT

  • Manufacturer Certified Training for your staff
  • No special equipment required beyond ENDOSURE Test
  • No biological sample collection or disposal required

ENDOSURE provides clinical evidence for practitioners who suspect endometriosis

Non-invasive Endometriosis GIMA Biomarker Screening

 
 

Endosure™ is an accurate yet non-invasive diagnostic test for endometriosis. The Endosure™ test uses an electroviscerography system (EVG), an analytical instrument that collects GastroIntestinal Myoelectrical Activity (GIMA) signals from the abdomen through dry electrodes. The test detects endometriosis presence by measuring a GIMA pattern unique to endometriosis sufferers (GIMA biomarker). Very similar to an electrocardiogram/EKG it’s easy to perform and provides simple, objective data.

Endosure™ provides clinical evidence for practitioners who suspect endometriosis in their patients with:

  • Dysmenorrhea and/or chronic pelvic pain
  • Infertility & miscarriage
  • Pre-pregnancy screening for endometriosis associated with the higher-risk for placenta previa, preeclampsia, preterm birth and post-partum hemorrhage.

 

Information for Providers

Talk to Us!

Contact us to learn more and bring endosure testing to your patients.

Tier 1 Diagnostic Test for Endometriosis – results in 30 minutes

How it works

Electroviscerography system (EVG) is an analytical instrument that collects myoelectrical activity signals from your gastrointestinal tract.  
The Endosure test records your GIMA pattern. This data is analyzed, then compared to the GIMA biomarker, a known digital “fingerprint” of people who suffer from endometriosis.2,3 

The result of this rapid, pain free and non-invasive diagnostic test supports your diagnosis of endometriosis and expedites the the process for treatment and management of the disease. 

ENDOSURE diagnostic test for endometriosis has regulatory approval in several countries for clinical use, and approval is pending in Australia, Europe and the USA, expected by 2025 year end.

Get in touch – book a demo – chat with us

Transform Your Practice Today

 
 

Join the revolution in endometriosis care. Offer your patients fast, accurate answers about endometriosis with EndoSure™.

Designed to empower healthcare professionals like you, results provide decision support for more informed decisions about your patient’s care. From 100+ painful periods to less than an hour – highly accurate, non-invasive endometriosis diagnosis support tools offer hope for faster solutions for your patients. Contact us below to learn more about offering this test. A member of our team will be in touch!

Name
Please give us permission to contact you. We respect your time and privacy.

Published Research: 

Mark Noar, John Mathias, Ajit Kolatkar. Validation of New GIMA Biomarker Signature of Endometriosis – Interim Data: Research Article. Advance. August 26, 2024.
DOI: 10.22541/au.172469630.08159498/v1

Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024;13(10):2866. Published 2024 May 13. doi:10.3390/jcm13102866

AI-Derived Threshold Score of Intraabdominal Myoelectrical Activity Predicts Presence and Stage of Endometriosis with 100% Accuracy, Noar, M., Journal of Minimally Invasive Gynecology, Volume 29, Issue 11, S4 – S5. DOI: 10.1016/j.jmig.2022.09.026